Intra Cellular Therapies shares owned by TD Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intra Cellular Therapies by TD Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $5.2M | 73k | 71.62 |
2020-09-30 | $434k | 17k | 25.66 |
2020-06-30 | $599k | 23k | 25.68 |
2020-03-31 | $549k | 36k | 15.37 |
2019-12-31 | $1.0M | 30k | 34.30 |
2019-06-30 | $193k | 15k | 12.95 |
2019-03-31 | $173k | 14k | 12.18 |
2018-12-31 | $162k | 14k | 11.41 |
2018-09-30 | $458k | 21k | 21.71 |
2018-06-30 | $666k | 38k | 17.67 |
2018-03-31 | $1.0M | 49k | 21.06 |
2017-03-31 | $228k | 14k | 16.29 |
2016-12-31 | $231k | 15k | 15.10 |
2016-09-30 | $216k | 14k | 15.21 |